Novelty Nobility Expands Manufacturing Pact With AGC Biologics in Japan
Novelty Nobility is expanding a manufacturing agreement with AGC Biologics to advance a bispecific antibody drug candidate in Japan. The candidate will progress through process development and good manufacturing practice (GMP) manufacturing at AGC Biologics’ facility in Chiba, Japan. AGC Biologics defines itself as a global pharmaceutical CDMO. Meanwhile, Novelty Nobility, based in South Korea,…
